NCT03822338 is a NA clinical trial of Pneumoperitoneum preconditioning in Ischemia Reperfusion Injury, sponsored by Nanjing First Hospital, Nanjing Medical University.

Who is sponsoring NCT03822338?

NCT03822338 is sponsored by Nanjing First Hospital, Nanjing Medical University.

What drugs are being tested in NCT03822338?

Interventions in NCT03822338: Pneumoperitoneum preconditioning, Sham-Pneumoperitoneum preconditioning.

What condition does NCT03822338 study?

NCT03822338 studies Ischemia Reperfusion Injury.

Is NCT03822338 still recruiting?

NCT03822338 is currently status unknown. Last updated 3 October 2022.

Last reviewed 2022-10-03 · How we verify

NCT03822338

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pneumoperitoneum Preconditioning for the Prevention of Renal Function After Laparoscopic Partial Nephrectomy

Status unknown NA Last updated 3 October 2022

What this trial tests

NA trial testing Pneumoperitoneum preconditioning in Ischemia Reperfusion Injury in 86 participants. Status unknown.

Timeline

1 January 2021

Primary endpoint
1 June 2023

1 June 2023

Quick facts

Lead sponsor	Nanjing First Hospital, Nanjing Medical University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	prevention
Enrollment	86
Start date	1 January 2021
Primary completion	1 June 2023
Estimated completion	1 June 2023
Sites	1 location across China

Drugs / interventions tested

Pneumoperitoneum preconditioning
Sham-Pneumoperitoneum preconditioning

Conditions studied

Ischemia Reperfusion Injury — all drugs for Ischemia Reperfusion Injury →

Sponsor

Nanjing First Hospital, Nanjing Medical University

Who can join

18 and older, any sex, with Ischemia Reperfusion Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study is designed to investigate the short-term and long-term renoprotective role of pneumoperitoneum preconditioning in patients undergoing laparoscopic partial nephrectomy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Pneumoperitoneum preconditioning for the prevention of renal function after laparoscopic partial nephrectomy: protocol for a double-blind randomised controlled trial.
Zhou C, Xu L, Xu Z, Ge Y, et al · · 2020 · PMID 32461289 · DOI 10.1136/bmjopen-2019-032002

Verify or expand the search:

Other recruiting trials for Ischemia Reperfusion Injury

Currently open trials in the same condition.

NCT05004610 — Hypertonic Lactate After Cardiac Arrest · Phase 2 · recruiting
NCT05992259 — Auricular Vagus Stimulation and STEMI · NA · recruiting
NCT05430620 — Intermittent Versus Continuous Surface O2 During HMP of DCD Kidneys · Phase 3 · recruiting
NCT04750616 — NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial · Phase 2 · recruiting
NCT04005469 — Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation · Phase 1, PHASE2 · recruiting

Other Nanjing First Hospital, Nanjing Medical University trials

Trials by the same sponsor.

NCT07349979 — PCI With Guideline-Directed Medical Therapy for HFpEF Patients With Ischemic Cardiomyopathy · NA · not yet recruiting
NCT07505056 — Jianpi Lishi Jiedu Granules for Prevention of Postoperative Recurrence in Colorectal Advanced Adenomas · Phase 3 · not yet recruiting
NCT07397234 — Thyroid Cartilage Plane VS Superior Laryngeal Nerve Space Block in Awake Tracheal Intubation · NA · not yet recruiting
NCT07455448 — Antibiotic Resistance of Helicobacter Pylori in Nanjing: A Cross-Sectional Study · completed
NCT07385885 — Ultrasound-guided Non-invasive Simulation in Anesthesia Residency Training · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03822338 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nanjing First Hospital, Nanjing Medical University
Last refreshed: 3 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03822338.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing